The 341C/T polymorphism in the GSTP1 gene is associated with increased risk of oesophageal cancer

Li et al. BMC Genetics 2010, 11:47 http://www.biomedcentral.com/1471-2156/11/47 RESEARCH ARTICLE Open Access The 341C/T polymorphism in the GSTP1 gene is associated with increased risk of oesophageal cancer Research article Dongping Li1,2, Collet Dandara3 and M Iqbal Parker*1,2 Abstract Background: The Glutathione S-transferases (GSTs) comprise a group of enzymes that are critical in the detoxification of carcinogens. In this study the effects of polymorphisms in these genes on the risk of developing oesophageal squamous cell carcinoma (OSCC) were evaluated in a hospital-based case-control study in two South African population groups. Genetic polymorphisms in GSTs were investigated in 245 patients and 288 controls samples by PCR-RFLP analysis. Results: The GSTP1 341T variant was associated with significantly increased risk of developing OSCC as observed from the odds ratios for the GSTP1 341C/T and GSTP1 341T/T genotypes (OR = 4.98; 95%CI 3.05-8.11 and OR = 10.9; 95%CI 2.43-49.1, respectively) when compared to the homozygous GSTP1 341C/C genotype. The risk for OSCC in the combined GSTP1 341C/T and T/T genotypes was higher in tobacco smokers (OR = 7.51, 95% CI 3.82-14.7), alcohol consumers (OR = 15.3, 95% CI 1.81-12.9) and those using wood or charcoal for cooking and heating (OR = 12.1, 95% CI 3.26-49) when compared to those who did not smoke tobacco, or did not consume alcohol or user other forms of fuel for cooking and heating. Despite the close proximity of the two GSTP1 SNPs (313A>G and 341C>T), they were not in linkage disequilibrium in these two population groups (D':1.0, LOD: 0.52, r2: 0.225). The GSTP1 313A/G polymorphism on the other hand, did not display any association with OSSC. The homozygous GSTT1*0 genotype was associated with increased risk of OSCC (OR = 1.71, 95%CI 1.18-2.46) while the homozygous GSTM1*0 genotype was associated with significantly decreased risk of OSCC in the Mixed Ancestry subjects (OR= 0.39, 95%CI 0.25-0.62). Conclusions: This study shows that the risk of developing OSCC in the South African population can be partly explained by genetic polymorphisms in GST coding genes and their interaction with environmental factors such as tobacco smoke and alcohol consumption. Background Oesophageal squamous cell carcinoma (OSCC) is the second most common cancer among African males in South Africa [1,2]. Although very little is known about the aetiology of OSCC in this population, several risk factors such as tobacco smoking, alcohol consumption and the prolonged use of wood or charcoal as sources of fuel for cooking and heating (resulting in excessive smoke inhalation), have generally been implicated [3,4]. Somatic mutations in the human pro-collagen genes [5], genetic polymorphisms in the androgen receptor gene [6], or * Correspondence: 1 International Centre for Genetic Engineering and Biotechnology (ICGEB), UCT Campus , Anzio Road Observatory 7925, Cape Town, South Africa Full list of author information is available at the end of the article genes coding for phase I and phase II detoxification enzymes [7-9], exposure to aflatoxin-, and fumonisincontaminated maize, human papilloma virus (HPV) infection [10] and a habit of regular forced vomiting have all been proposed as major risk factors for OSCC among South Africans. Recent data imply that the environmental risk factors may be modified by polymorphisms in the carcinogen metabolizing genes i.e. gene-environment interactions [7]. The glutathione S-transferase (GST) family of enzymes play an important role in the detoxification of carcinogens by catalyzing the conjugation of glutathione (GSH) to electrophilic compounds [11-14]. Multiple tissue-specific GST isoforms accommodate a diverse range of substrates, thus conferring tissue specificity in the handling © 2010 Li et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Li et al. BMC Genetics 2010, 11:47 http://www.biomedcentral.com/1471-2156/11/47 of certain carcinogens. Although there is evidence for the role of genetic polymorphisms in the alpha (A), mu (M), theta (T) and pi (P) GST gene families in a number of cancers [15-19], the current study investigated the role of the latter three in OSCC among South Africans because of their biological relevance in the metabolism of known carcinogens, allelic frequency and implications in previous epidemiological studies on cancer [15-19]. GSTM1 is principally expressed in the liver, with low levels in extra hepatic tissues. Genetic polymorphisms in the gene are due to either gene deletion (giving rise to GSTM1*0) or a single nucleotide change 534 C/G (causing the replacement of lysine 172 by aspartic acid) resulting in two alleles GSTM1*A and GSTM1*B, whose gene products do not show any differences in activity [13,14]. The GSTM1*0 occurs at different frequencies in different populations: 19%-33% in Africans [15-17], 30%-52% among Caucasians [18,19] and 55% among Asians [20]. GSTT1 on the other hand, is expressed at high levels in extra hepatic tissues, including the kidney, liver and the gastrointestinal tract, suggesting an important role in the protection against carcinogens and other xenobiotics in these tissues [13,21,22]. Two GSTT1 variants have been identified, one is an entire gene deletion (referred to as GSTT1*0) [23] and the second is a single base change, 310 A/T (referred to as GSTT1*B) which is associated with abolished GSTT1 activity [24]. There is a clear ethnic variation in the distribution of the homozygous GSTT1 null genotype occurring in 10%-26% Africans and Caucasians [15-18] and 55%-75% in Koreans, Japanese and Chinese [20,25,26]. GSTP1 is the major GST expressed in extra hepatic tissues such as the lungs and the oesophagus with very little expression in the liver [13,21,22] and has been shown to be over expressed in several malignant tissues compared to their matched normal tissues [27]. Two single nucleotide polymorphisms (SNPs) in GSTP1 resulting in amino acid substitutions that affect enzyme activity function are rs1695 (formerly rs947894 which is due to an A313G substitution resulting in an Ile105Val amino acid change) and rs1138272 (formerly rs1799811 which is due to a C341T substitution resulting in an Ala114Val amino acid change) [28-30]. The GSTP1 313G variant has been widely studied and occurs at frequencies of 14%-20% among Black Africans [15,16], 28%-32% among Caucasians [31] and 14-18% among Asians [29,32]. Very few studies have investigated the role of the GSTP1 341T variant in the development of OSCC. We investigated the role of the GSTM1, T1 and P1 polymorphisms in OSCC because of the conflicting reports on their role in gastric, breast and lung cancers [33-36]. Our data suggest that the GSTP1 341T va (...truncated)